Navigation Links
CareFusion Corporation Launches International Jazz Festival Series

NEW YORK, July 7 /PRNewswire-FirstCall/ -- CareFusion Corporation, the company that will become public following the planned spinoff of Cardinal Health's clinical and medical products businesses, today announced the CareFusion Jazz Festival Series at an event held in New York.

CareFusion created the CareFusion Jazz Festival Series to support the launch of its new brand and recognize individuals and organizations working to improve patient care. The new medical technology company combines its proven technologies with information to help measurably improve the delivery of care.

The Series comprises some of the largest and oldest jazz festivals in the world, attracting both big-name and up-and-coming artists.

"There is a clear connection between jazz and medicine that provides the perfect opportunity to launch our new brand, raise funds for and awareness of patient safety and help support and preserve the arts," said David Schlotterbeck, CEO of CareFusion. "Both jazz and the practice of medicine embrace innovation, performance and change. Jazz has also been used to teach listening skills to medical students and resonates with our customers. In addition, the musicians playing at these festivals are the best and the brightest - a great fit for our company whose products are recognized as leaders in our industry."

George Wein, world-famous jazz impresario and founder of the Newport Jazz Festival said, "This is a critical time to invest in the arts. CareFusion is re-igniting a 34-year tradition in New York City and supporting cultural institutions around the world."

The CareFusion Jazz Festival Series will open in Newport, R.I. The kickoff event will be George Wein's CareFusion Jazz Festival 55, the oldest of the festivals and the one that has set the tradition for jazz festivals as they are known today. The full schedule includes:

  • George Wein's CareFusion Jazz Festival 55 (Newport, R.I.), Aug. 7 - 9, 2009
  • Chicago Jazz Festival presented by CareFusion, Sept. 4 - 6, 2009
  • CareFusion Presents Dizzy's Den at the Monterey Jazz Festival, Sept. 18 - 20, 2009
  • CareFusion Manly Jazz Festival (Australia), Oct. 3 - 5, 2009
  • CareFusion Jazz Festival Paris, Oct. 16 - 24, 2009
  • CareFusion New York Jazz Festival, June 2010 (exact dates to be determined)

As part of the Festival Series, CareFusion will broadcast live to hospitals the performances of select festival artists. Caregivers and administrators from hospitals across the United States, Europe and Australia will also be invited to special VIP events at the festivals to raise funds and awareness for a new health care safety campaign named Rhythm of Care.

Rhythm of Care will bring together organizations and people from health care to promote best practices and honor safety leaders working to improve how care is delivered worldwide.

Medication errors and hospital-acquired infections are two of the biggest challenges facing the medical industry. Reports cite the annual cost of medication errors to be $3.5 billion in the U.S. and $3 billion per year in top five European countries. In addition, there are an estimated 7 million hospital-acquired infections worldwide annually, costing as much as $20 billion per year in the U.S alone.

"Building a safer and more efficient approach to health care is a top priority for everyone - hospitals, caregivers, patients and government," said Schlotterbeck. "That is why CareFusion plans to partner with nonprofit safety organizations to create Rhythm of Care. We want to honor individuals in health care that are pioneering new ways to improve safety and share their ideas with others."

About CareFusion Corporation

CareFusion Corporation, a wholly owned subsidiary of Cardinal Health (NYSE: CAH), is expected to become a public company from the planned spinoff of Cardinal Health's clinical and medical products businesses. The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of health care. CareFusion develops market-leading technologies including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, AVEA and Pulmonetic Systems ventilation and respiratory products, ChloraPrep(R) and MedMined(TM) services for infection prevention, neurological monitoring and diagnostic products, V. Mueller(R) surgical instruments, and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has applied to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at

About George Wein

Jazz Impresario and NEA Jazz Master George Wein is considered to be as much a legend as his festivals. Through his company, Festival Productions, he has spearheaded hundreds of music events annually since 1954 when he produced the first Newport Jazz Festival - an event that started the "festival era," according to jazz critic Leonard Feather. At 83, Wein has as much creative fuel as he did when he started that festival and advanced the concept of live music. He pioneered the concept of sponsor association with music events and continues that tradition with CareFusion. Honors and awards have been bestowed upon him by AARP, Studio Museum of Harlem, Presidents Bill Clinton and Jimmy Carter, the Government of France and other organizations around the world. Wein's autobiography, Myself Among Others: A Life in Music, which chronicles his life in jazz, was recognized by the Jazz Journalists Association as 2004's best book about jazz. He has also been named 2009's Events Producer of the Year. In addition to his life in jazz, Wein has a long history of involvement with philanthropy and the arts.

Cautions Concerning Forward-Looking Statements

This news release contains forward-looking statements addressing the planned spinoff of Cardinal Health's clinical and medical products businesses as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10, as amended, and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.

SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CareFusion Files Amended Form 10 Registration Statement With SEC
2. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
3. CareFusion Names Robert Friel to Board of Directors
4. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
5. CareFusion Names Edward Borkowski as Chief Financial Officer
6. CareFusion Corporation Files Form 10 Registration Statement
7. AMERIGROUP Corporation to Discuss Second Quarter Earnings on July 31
8. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
9. Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimers Immunotherapy Program and Equity Investment
10. Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc.
11. Baxa Corporations Dennis Tribble, PharmD, Now Profiled at for Media and Professional Access
Post Your Comments:
(Date:10/9/2015)... ... 09, 2015 , ... The American Osteopathic Foundation (AOF) has ... Education J. Michael Finley, DO, as the recipient of the 2015 W. Douglas ... on graduate medical education opportunities for osteopathic residents, and his dedication to promoting ...
(Date:10/9/2015)... ... October 09, 2015 , ... With the FCPX LUT Vibrance pack ... footage. A LUT is a Lookup Table that contains a mathematical formula for modifying ... the table. This pack comes with 60 vibrant CUBE LUT files. , ...
(Date:10/9/2015)... ... October 09, 2015 , ... Smoke alarms can save lives. In ... the risk of dying in reported home fires in half. As part of Fire ... alarms are property installed and maintained. , Half of home fire deaths result from ...
(Date:10/9/2015)... CA (PRWEB) , ... October 09, 2015 , ... Head ... Center for the elite developmental camp at the Karolyi Ranch in Huntsville, Texas on ... Katreece Stone, Head Over Heels girls team head coach and executive director, said. “It's ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Asthma and Allergy Foundation ... for Disease Control and Prevention (CDC) to improve the knowledge and skills of underserved ... been awarded a project by the CDC and allows AAFA to continue vital efforts ...
Breaking Medicine News(10 mins):
... and about 150 die every year. // ... Medicine in New York recently analyzed 31 allergy deaths. They ... teenagers or young adults. They were away from home when ... ,"We were surprised that so few people had gotten correct ...
... papers published in The Lancet on adolescent health, the current ... parents.// The infections of the earlier times like polio and ... drug abuse etc. The only silver lining to this issue ... ,Obesity in adolescents has increased fourfold between 1970 and ...
... the heart disease medicine of Sanofi-Aventis will be made indigenously ... Tuesday.// ,As per the offer made by Sanofa-Aventis, ... imitated version of the drug. The statement released by the ... will benefit the poorer Thai patients. According to a health ...
... be the latest trend which is making waves in the ... develop their skills to make sure the evaluation of the ... ,More than 170 physician performance measures have been ... Physician Consortium for Performance Improvement organized by the American Medical ...
... has asked the aerated drink manufacturers Pepsico and Coca Cola ... The Ganguly report had deduced that pesticide residues were found ... should be furnished within six weeks. ,Centre ... public interest litigation which stated that that the cola drinks ...
... computed tomography (CT) screening plays a vital role in ... screening determines how early the cancer is diagnosed. This ... treatment which can be curative,” said NY-ELCAP principal investigator ... Weill Cornell Medical College and chief of the divisions ...
Cached Medicine News:
(Date:10/9/2015)... , Oct. 9, 2015  Impax Laboratories, Inc. ... will release its third quarter 2015 financial results on ... the U.S. financial markets. The Company will host a ... at 8:30 a.m., Eastern Time on November 9, 2015.  ... . --> The financial results and live ...
(Date:10/9/2015)... 9, 2015 Eli Lilly and Company (NYSE: ... and approximately 50 new jobs to its research and development ... New York, New York . ... space will include a translational immuno-oncology hub and a Lilly ... collaborative access to cutting-edge drug discovery capabilities, including chemistry and ...
(Date:10/9/2015)...   --> --> Phase ... San Diego, California , by Dr. Tom Lyon , ... Center, on 9 th October 2015 at 8:30a.m. PDT. ... Tom Lyon , Director of Orthopaedics and Chief of Orthopaedic Trauma, ... 8:30a.m. PDT. --> Kuros Biosurgery AG, a biotechnology company ...
Breaking Medicine Technology:
... Talecris Biotherapeutics (Nasdaq: TLCR ) today ... Administration for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more ... manufacturing technology. , Like PROLASTIN, the market leader ... the treatment of alpha1-antitrypsin (AAT) deficiency, a genetic ...
... BRIDGEWATER, N.J., Oct. 16 Sanofi-aventis U.S. announced that ... marketing approval for Elitek® (rasburicase) to be used for ... in adult patients with leukemia, lymphoma, and solid tumor ... in tumor lysis syndrome (TLS) and subsequent elevations of ...
Cached Medicine Technology:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: